Show simple item record

dc.contributor.editorGuerrero, Anna C.en_US
dc.creatorMeek, Caroline
dc.date.accessioned2018-09-10T17:22:43Z
dc.date.available2018-09-10T17:22:43Z
dc.date.created2018-09-10
dc.identifier.urihttp://hdl.handle.net/10776/13085
dc.descriptionThe Food and Drug Administration’s Content and Format for Labeling for Human Prescription Drugs Rule, or the 1979 Labeling Rule, first assessed the risk of prescription drugs in pregnant women and fetuses. Prior to 1979, drug labels were only required to state true information, but there were no requirements for content or format. The 1979 Labeling Rule established a required format for all prescription drug labels, which included assigning drugs to a risk category for pregnant and lactating women. Those risk categories indicated what level of risk a drug posed to a pregnant woman, fetus, or breastfeeding infant based on experiments and case studies. The 1979 Labeling Rule sought to improve the safety and efficacy of drugs and established the first classification system for identifying the risks prescription drugs posed to pregnant women, fetuses, and breastfeeding infants.en_US
dc.format.mediumtext/xhtmlen_US
dc.language.isoen_USen_US
dc.language.isoen_USen_US
dc.publisherArizona State University. School of Life Sciences. Center for Biology and Society. Embryo Project Encyclopedia.en_US
dc.relation.ispartofEmbryo Project Encyclopediaen_US
dc.rightsCopyright Arizona Board of Regentsen_US
dc.subjectLawen_US
dc.subject.lcshDrugs--Labelingen_US
dc.subject.lcshDrugs--Labeling--Law and legislationen_US
dc.subject.lcshTeratogenic agentsen_US
dc.subject.lcshFetus--Effect of drugs onen_US
dc.subject.lcshPregnancyen_US
dc.subject.lcshUnited States. Food and Drug Administrationen_US
dc.subject.meshDrug Approvalen_US
dc.subject.meshLegislation, Drugen_US
dc.subject.meshUnited States Food and Drug Administrationen_US
dc.subject.meshDrug Labelingen_US
dc.subject.meshProduct Labeling, Drugen_US
dc.subject.meshDrug Packagingen_US
dc.subject.meshPregnant Womenen_US
dc.subject.meshTeratogensen_US
dc.subject.meshFetusen_US
dc.titleUS Food and Drug Administration’s Requirements on Content and Format for Labeling for Human Prescription Drugs Rule (1979)en_US
dc.typeArticleen_US
dc.typeTexten_US
dc.rights.licenseLicensed as Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported (CC BY-NC-SA 3.0) http://creativecommons.org/licenses/by-nc-sa/3.0/en_US
dc.subject.embryoLegalen_US
dc.subject.tagdrug labelen_US
dc.subject.tagdrug lawen_US
dc.subject.tag1979 Labeling Ruleen_US
dc.subject.tagPregnancyen_US
dc.subject.tagdrug safetyen_US
dc.description.typeArticlesen_US
dc.date.createdstandard2018-09-10en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record